Related Articles
Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients
Surgery following neoadjuvant chemotherapy for non‑small‑cell lung cancer patients with unexpected persistent pathological N2 disease
Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma
Efficacy of consolidation of immune checkpoint inhibitor after chemoradiation for unresectable, locally advanced PD‑L1 negative non‑small cell lung cancer: A systematic review and meta‑analysis
ERCC1 and XRCC1 expression predicts survival in bladder cancer patients receiving combined trimodality therapy